CLS’s Innovation Showcase, taking place December 12 at SmartLabs Oyster Point, will spotlight California’s transformative early-stage innovation and foster vital connections for entrepreneurs, investors, and corporate partners. 

• Investor Partnering Forum | Each participating VC/CVC will select up to six (6) companies for 20-minute conversations. Take advantage of this exclusive opportunity to pitch to top life sciences investors and organizations, including Alexandria Ventures Investments, Remiges Ventures, Pfizer Ignite, SR One, Danaher Ventures, Phase Two Ventures, Life Science Angels, among others. Apply today! 
• Keynote | Christian R. Schubert, Head of AbbVie Ventures
• Panel Discussion | De-risking and funding strategies for startups through early collaboration with pharma partners
• Pitch Sessions | 2023 Fall FAST cohort. Click here to learn more about the 12 presenting companies. 
• Networking Reception | 5:00-6:30pm 

For the full agenda and to register, click here. 

Let CLS jumpstart your efforts at one of the year's most important weeks for BD&L and fundraising.

Roadshow Preparation Bootcamp

Join CLS’s next Positioning for Capital virtual program, presented by Life Science Nation, on November 14, 2023. 

LSN speakers will discuss roadshow preparation and the success factors for engaging investment at RESI JPM, including establishing your ‘entrepreneurial agency’. Register here.

CLS is partnering with the Bullpen, an exclusive group that gathers life science investors and CxOs with a shared goal of helping each other and preparing for JPM Week.

A limited number of FAST alumni and CLS startup members will be offered complementary participation in workshops, peer coaching, JPM partnering opportunities as well as discounts to local SF hotels. Please contact zernicke@christiaanco.com or to learn more, visit www.bullpen.ventures.

RESI JPM January 9-11 | Marine’s Memorial Club
As a title sponsor for RESI JPM, CLS member start-ups receive an unprecedented level of exposure:

• FAST Fall founders will receive complimentary 3-day ticket to RESI JPM ($2,295 value)
• 50% off standard 3-day hybrid registration for CLS Seed Stage member companies who have raised under $5M USD equity | discount code CLSSEED50
• $350 off standard 3-day registration for CLS members who have raised over $5M USD equity | discount code CLS350
• $100 off standard 2-day virtual registration for CLS members wanting to attend virtually | discount code CLSVIRTUAL100
• Free ticket for 2nd attendee with Innovator’s Pitch Challenge (IPC) package: $3,495 | No discount code required | Startups must submit pitch application by Wednesday. Nov. 22. Apply here. 

Avance Clinical | Global clinical CRO 

Avance Clinical is the largest specialist Australian and US CRO delivering quality clinical trials in Australia, New Zealand and North America for international biotechs. The CRO has been delivering clinical drug development services for international biotechs for FDA and EMA regulatory approval, for more than two decades. CLS members can take advantage of generating first in human data potentially earlier while using R&D tax credit program when conducting first in human trial in Australia. Contact Kevin Geno for more information.

Pfizer Ignite | Supports de-risking of innovative technologies

Pfizer Ignite is an end-to-end developmental and clinical service offering for biotech innovators to help advance novel therapies to market. It includes access to Pfizer’s resources, scale, and expertise and leverages their track record in the commercialization of breakthroughs. Pfizer Ignite works with innovative companies that are aligned with their priority therapeutic areas and are ready to move from candidate selection through Phase II. Learn more here.

WUXI Biologics – Enable The Molecule Program | R&D credit opportunity for FAST alumni 

WuXi Biologics’ Enable the Molecule Program works with accelerators, seed/venture capital firms, incubators, and other similar programs to provide startups with the necessary tools and resources to expedite biologics and vaccine development. Program features include R&D support, technical assistance, training, resources and access to world-class technology and drug development platforms – all designed to help startups launch quickly and on a path toward accelerated drug development.

2023 Silicon Valley Leaders Forum HealthTech Showcase November 3 | San Mateo
The event takes advantage the unique environment of innovation in Silicon Valley by connecting early-stage start-ups with venture capitalists and advisors. The proceeds of the event benefit the American Diabetes Association. Members who register through this link receive entry for $600.

Johnson & Johnson Innovation – Strategies for Success: A Guide to Licensing Collaboration Structures November 7 | South San Francisco
JLABS @ SSF will host experts from Cooley LLP to discuss key considerations for structuring licensing and partnering deals to achieve the corporate objectives of licensors and licensees and to maximize the likelihood of a successful collaboration.

2023 Symposium on Biomanufacturing November 30 | Los Angeles
This hybrid event will focus on translational medicine, stem cell science, and cell therapy biomanufacturing for clinical trials. Breakfast and lunch will be provided for in-person attendees. Topics to include: iPSC derived therapies, cellular immunotherapies, smart manufacturing / automation, genetically engineered therapies and regulatory and quality considerations in manufacturing.

Larta: ECO 23' LA December 4-6 | Los Angeles
ECO is a new multidisciplinary festival and ecosystem gathering, designed to foster innovation for a sustainable planet. Los Angeles serves as a crucial platform for learning, collaboration, and practical solutions.

Biotech Showcase (Including Medtech Showcase) January 8-10 | Hilton SF Union Square 
Biotech Showcase is a premier investor conference committed to creating a platform for private and micro-mid-cap biotechnology companies. CLS members receive a $200 discount off registration This discount also applies to companies that request a presentation slot. To register, click here and select the presentation package that best applies, click on "Apply to Present" and in the "Additional Comments" field of application form and enter the VIP code supCALIFESCIENCES2024

Informa BIOMEDevice Innovation Showcase November 15-16 | Santa Clara
The perfect opportunity for founders and entrepreneurs to showcase their most cutting-edge products and services. The Startup Stadium and Startup Pavilion offer exclusive exposure and publicity, including pre-show and post-event promotion to industry media. CLS members receive a free expo pass and save 20% off a Master Class conference pass with code CLS23

Fierce JPM Week January 9-10 | Hyatt Regency San Francisco 
From thought-provoking discussions on the ever-evolving deal dynamics within the industry to unique insights on the regulatory landscape, treatment breakthroughs, and the strategic deployment of AI, some of the greatest minds in pharma and healthcare will convene to explore the most pressing issues and exciting opportunities on the horizon. CLS members can receive a 25% discount on registration by using code CLS24

New SBIR Foreign Disclosure Requirements: How Does It Impact Your Company? Following reauthorization by Congress of the SBIR/STTR Programs in 2022, there are new rules companies should familiarize themselves with concerning required disclosures of foreign affiliations or relationships with foreign countries. In addition to mandating disclosures prior to receiving SBIR awards, companies must also regularly update NIH following any changes to a disclosure. View this webinar organized by the Biotechnology Innovation Organization (BIO) for a comprehensive discussion on how to effectively navigate these new rules as you apply for SBIR awards.

The U.S. market access landscape is complex, proving safety and efficacy is no longer a guarantee of commercial success. CLS’s three-part series, presented by Hogan Lovells, provides the basics of government and commercial payer rules, offer hypotheticals that bring those rules to life, and help prepare you for the market’s evolving focus on value-delivery. View the archived sessions:

1. The Foundation: The Basics of Market Access and Why They Matter Before Phase IIIs
2. Bringing to Life: What Does an Early-Stage Market Access Strategy Look Like?
3. Future-Proofing: How to Prepare a Value-Based Market Access Strategy

Free one year subscription to USP-NF for CLS Startup Life Science Member Companies!

The United States Pharmacopeia (USP) is extending a free one-year subscription to USP-NF, with active CLS membership, when enrolled in two or more CLSAdvantage/BIO Business Solutions Cost Savings programs. USP-NF is an online subscription that contains public standards for drug substances, dosage forms, biologics, medical devices, and other therapeutics. Check out more details here.